Literature DB >> 9889270

Search for differences in post-transcriptional modification patterns of mitochondrial DNA-encoded wild-type and mutant human tRNALys and tRNALeu(UUR).

M Helm1, C Florentz, A Chomyn, G Attardi.   

Abstract

Post-transcriptional modifications are characteristic features of tRNAs and have been shown in a number of cases to influence both their structural and functional properties, including structure stabilization, amino-acylation and codon recognition. We have developed an approach which allows the investigation of the post-transcriptional modification patterns of human mitochondrial wild-type and mutant tRNAs at both the qualitative and the quantitative levels. Specific tRNA species are long-term labeled in vivo with [32P]orthophosphate, isolated in a highly selective way, enzymatically digested to mononucleotides and then subjected to two-dimensional thin layer chromatographic analysis. The wild-type tRNALysand the corresponding tRNALyscarrying the A8344G mutation associated with the MERRF (Myoclonic Epilepsy with Ragged Red Fibers) syndrome exhibit the same modified nucleotides at the same molar concentrations. By contrast, a quantitatively different modification pattern was observed between the wild-type tRNALeu(UUR)and its counterpart carrying the A3243G mutation associated with the MELAS (Mitochondrial Myopathy, Encephalopathy with Lactic Acidosis and Stroke-like episodes) syndrome, the latter exhibiting a 50% decrease in m2G content. Complementary sequencing of tRNALeu(UUR)has allowed the localization of this modification at position 10 within the D-stem of the tRNA. The decreased level of this modification may have important implications for understanding the molecular mechanism underlying the MELAS-associated mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889270      PMCID: PMC148244          DOI: 10.1093/nar/27.3.756

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

Review 1.  Disease-related versus polymorphic mutations in human mitochondrial tRNAs. Where is the difference?

Authors:  C Florentz; M Sissler
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

Review 2.  Mitochondrial threshold effects.

Authors:  Rodrigue Rossignol; Benjamin Faustin; Christophe Rocher; Monique Malgat; Jean-Pierre Mazat; Thierry Letellier
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

3.  Structural probing of a pathogenic tRNA dimer.

Authors:  Marc D Roy; Lisa M Wittenhagen; Shana O Kelley
Journal:  RNA       Date:  2005-03       Impact factor: 4.942

4.  Comparative analysis of the pathogenic mechanisms associated with the G8363A and A8296G mutations in the mitochondrial tRNA(Lys) gene.

Authors:  Belén Bornstein; José Antonio Mas; Clarice Patrono; Miguel Angel Fernández-Moreno; Emiliano González-Vioque; Yolanda Campos; Rosalba Carrozzo; Miguel Angel Martín; Pilar del Hoyo; Filippo M Santorelli; Joaquín Arenas; Rafael Garesse
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

5.  Sequence variation in the tRNA genes of human mitochondrial DNA.

Authors:  Tiina Vilmi; Jukka S Moilanen; Saara Finnilä; Kari Majamaa
Journal:  J Mol Evol       Date:  2005-05       Impact factor: 2.395

6.  Use of DNAzymes for site-specific analysis of ribonucleotide modifications.

Authors:  Martin Hengesbach; Madeleine Meusburger; Frank Lyko; Mark Helm
Journal:  RNA       Date:  2007-11-12       Impact factor: 4.942

Review 7.  Detecting RNA modifications in the epitranscriptome: predict and validate.

Authors:  Mark Helm; Yuri Motorin
Journal:  Nat Rev Genet       Date:  2017-02-20       Impact factor: 53.242

8.  Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome.

Authors:  Jiqiang Ling; Hervé Roy; Daoming Qin; Mary Anne T Rubio; Juan D Alfonzo; Kurt Fredrick; Michael Ibba
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

9.  Decreased mitochondrial tRNALys steady-state levels and aminoacylation are associated with the pathogenic G8313A mitochondrial DNA mutation.

Authors:  Sandra R Bacman; David P Atencio; Carlos T Moraes
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  Tertiary network in mammalian mitochondrial tRNAAsp revealed by solution probing and phylogeny.

Authors:  Marie Messmer; Joern Pütz; Takeo Suzuki; Tsutomu Suzuki; Claude Sauter; Marie Sissler; Florentz Catherine
Journal:  Nucleic Acids Res       Date:  2009-09-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.